Skip to content

evaluation the effect of virtual pulmonary rehabilitaion on covid 19 patients

evaluation the effect of virtual pulmonary rehabilitation on the outcome and quality of life of COVID 19 patients after recovery from the acute phase

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200930048892N1
Enrollment
70
Registered
2020-10-18
Start date
2020-10-20
Completion date
Unknown
Last updated
2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID 19.

Interventions

Intervention group: virtual pulmonary rehabilitation in the form of breathing exercise.

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Definite diagnosis of covid 19 with PCR Hospitalization during the acute phase of the disease Lung involvement with a typical pattern of covid 19 in chest X ray or chest CT scan Being clinically stable Being able to understand and perform the virtual respiratory exercises as given to them in the study Age > 18 and < 60 years

Exclusion criteria

Exclusion criteria: COPD, asthma and any other respiratory disease Neuromuscular disorders that affect lung function History of ischemic heart disease, congestive heart failure and uncontrolled hypertension Asymptomatic carriers Sever comorbid conditions Disagree to participate in the study Lack of access to the internet and virtual applications

Design outcomes

Primary

MeasureTime frame
The perceived dyspnea severity during daily activities. Timepoint: Before intervention and 8 weeks after study. Method of measurement: Medical Research Council Scale.;The severity of dyspnea. Timepoint: Before intervention and 8 weeks after study. Method of measurement: Modified Borg Scale.;General health-related quality of life. Timepoint: Before intervention and 8 weeks after study. Method of measurement: Short-Form 36 (SF-36).;Psychological state and mood disorder. Timepoint: Before intervention and 8 weeks after study. Method of measurement: The Hospital Anxiety and Depression Scale (HADS).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFariba Erfani

Shiraz University of Medical Sciences

erfanif70@gmail.com+98 71 5383 8166

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026